Menu
close
Please contact us for more information or to learn if you are eligible to participate.
This is a multicenter, randomized, study to evaluate the safety, immunogenicity, and efficacy of VRC-ZKADNA090-00-VP (Zika virus wildtype DNA vaccine) or placebo. The primary objectives are to evaluate the safety and efficacy of the vaccine compared to placebo.
Principal Investigator | Dynio Honrubia, MD |
Co-PI | Luis Cantu Jr. |
Sponsor | National Institute of Allergy and Infectious Diseases (NIAID) Vaccine
Research Center (VRC) |
Type of Trial | Interventional |